Clinical trial
12 Week Efficacy of Tiotropium Versus Placebo in Patients With Mild COPD…
NCT00144196 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00144196 |
|---|---|
| Title | 12 Week Efficacy of Tiotropium Versus Placebo in Patients With Mild COPD According to Swedish Guidelines (SPIRIMILD) |
| Official title | A 12-week Double-blind, Randomised, Parallel-group, Multi-centre Study Evaluating the Efficacy of Tiotropium Versus Placebo in Patients With Mild COPD, According to Swedish Guidelines (SPIRIMILD) |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pulmonary Disease, Chronic Obstructive |
| Intervention type | Drug |
| Interventions | tiotropium (Spiriva) |
| Enrollment | 224 |
| Start date | Mar 11, 2004 |
| Primary completion | Jul 25, 2005 |
| Completion | Jul 25, 2005 |
| First posted | Sep 5, 2005 |
| Last update posted | Dec 5, 2023 |
| Countries | Sweden |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: